All articles by Manish Kumar
Manish Kumar
Sophia Genetics debuts new generation of Sophia DDM platform
The new platform features an upgraded architecture for efficient processing of large datasets and enhances the user experience with access to advanced multimodal analytics modules
Select Medical to acquire Oklahoma-based Valir Rehabilitation Hospital
Valir Health provides innovative solutions in outpatient physical therapy, hospice care, inpatient rehabilitation, and PACE- Program of All-Inclusive Care for the Elderly
Mallinckrodt’s Therakos Cellex System gets new EU CE Certification
Therakos Cellex Photopheresis System is a fully integrated and validated Extracorporeal Photopheresis system designed to treat various immune-mediated diseases
BD completes Edwards’ Critical Care group acquisition for $4.2bn
BD Advanced Patient Monitoring will operate as a separate unit within BD’s Medical segment, based in Irvine, California, and led by Katie Szyman, formerly Edwards’ corporate vice president of Critical Care
Steward Health Care announces sale of Wadley Regional Medical Center in Texarkana, Texas
The transaction is subject to customary closing conditions, including Bankruptcy Court and regulatory approvals
Claritas NucMed Technologies gets approval for Brazilian subsidiary
Claritas NucMed Tech Brazil will partner with New Vida Medicamentos e Produtos to deploy software suite for PET and SPECT with medical institutions throughout the country
Global Heart Hub shares insights from elevated cholesterol programme
The initiative assessed patients from Brazil, Australia, and the US to gain insights into how HCPs can provide personalised care through shared decision-making
Evonik and ICIG complete sale of superabsorbents business
ICIG takes over production facilities at five locations in Germany and the United States
LHSC, SHC Canada partner on orthopaedic care, research, and education
Under the partnership, families in southwestern Ontario will get access to specialised paediatric orthopaedic care while Shriners Hospitals will continue to handle more complex cases
WuXi announces first high-scale GMP manufacturing using WuXiUI platform
Launched in 2023, the WuXiUI platform enhances productivity across various CHO and other mammalian cell lines to support global clients in meeting the growing demand for therapeutic proteins and antibodies